Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)
India · Delayed Price · Currency is INR 57.77
+0.23 (0.40%)
Sep 24, 2026, 3:26 PM IST
NSE:KREBSBIO Market Cap
NSE:KREBSBIO has a market cap or net worth of 1.23 billion as of September 23, 2026. Its market cap has decreased by -29.63% in one year.
Market Cap
1.23B
Enterprise Value
3.48B
Revenue
252.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.77
ChartMarket Cap Chart
Since January 2, 2004, NSE:KREBSBIO's market cap has decreased from 1.64B to 1.23B, a decrease of -25.03%. That is a compound annual growth rate of -1.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 1.23B | -18.15% |
| Dec 31, 2025 | 1.50B | -24.71% |
| Dec 31, 2024 | 1.99B | 18.08% |
| Dec 29, 2023 | 1.69B | -29.33% |
| Dec 30, 2022 | 2.39B | -45.14% |
| Dec 31, 2021 | 4.36B | 60.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 7.65B |
| Amanta Healthcare | 7.30B |
| Valiant Laboratories | 6.90B |
| Nectar Lifesciences | 2.12B |
| Brooks Laboratories | 1.74B |
| Par Drugs and Chemicals | 1.63B |
| Balaxi Pharmaceuticals | 1.29B |
| Alpa Laboratories | 1.25B |